Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Follow on public offering	Follow on public offering Common Stock	Follow on public offering Additional Paid-in Capital	At the market offering	At the market offering Common Stock	At the market offering Additional Paid-in Capital
Beginning balance at Dec. 31, 2021	$ 284,018	$ 56	$ 582,844	$ (298,641)	$ (241)
Beginning balance, shares at Dec. 31, 2021		53,031,978
Exercise of stock options	282		282
Exercise of stock options (in shares)		91,044
Vesting of early exercised stock options	2		2
Issuance of common stock, value						$ 107,622	$ 3	$ 107,619	$ 3,098		$ 3,098
Issuance of common stock, shares							3,250,000			126,522
Release of restricted stock units	0
Stock-based compensation expense	4,099		4,099
Unrealized losses on investments	(592)				(592)
Net Loss	(38,986)			(38,986)
Ending balance at Mar. 31, 2022	359,543	$ 59	697,944	(337,627)	(833)
Ending balance, shares at Mar. 31, 2022		56,499,544
Beginning balance at Dec. 31, 2022	953,613	$ 82	1,476,018	(522,126)	(361)
Beginning balance, shares at Dec. 31, 2022		79,470,670
Exercise of stock options	502	$ 1	501
Exercise of stock options (in shares)		100,964
Vesting of early exercised stock options	2		2
Issuance of common stock, value	41,787									$ 1	$ 41,786
Issuance of common stock, shares										1,041,536
Release of restricted stock units	(727)		(727)
Release of restricted stock units, shares		27,681
Stock-based compensation expense	9,648		9,648
Unrealized losses on investments	408				408
Net Loss	(60,462)			(60,462)
Ending balance at Mar. 31, 2023	$ 944,771	$ 84	$ 1,527,228	$ (582,588)	$ 47
Ending balance, shares at Mar. 31, 2023		80,640,851